Testing Nivolumab and Ipilimumab Immunotherapy With or Without the Targeted Drug Cabozantinib in Recurrent, Metastatic, or Incurable Nasopharyngeal Cancer

Clinical trial NCT05904080 · SUSPENDED

Trial details

NCT number: NCT05904080
Sponsor: National Cancer Institute (NCI)
Status: SUSPENDED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Nasopharyngeal Carcinoma Recurrent Nasopharyngeal Carcinoma Stage IV Nasopharyngeal Carcinoma AJCC v8

Start date: 2024-02-19
Primary completion: 2028-06-16
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.